Ansell Ltd
PD1A
Company Profile
Business description
Ansell is a leading supplier of protective gloves and other wearable PPE for use in healthcare and industrial settings, each contributing about 50% of revenue. Industrial contributes slightly higher EBIT owing to higher margins. The company holds more than 500 patents, and most sales come from its key branded product ranges. Products are sold in about 100 countries, mostly via distributors. Approximately half of revenue is from North America, and about one-third is from Europe, the Middle East, and Asia. Latin America and Asia-Pacific each contribute about 10%.
Contact
678 Victoria Street
Level 3
Richmond
MelbourneVIC3121
AUST: +61 392707222
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
Employees
15,409
Stocks News & Analysis
stocks
Tesla: valuation is key consideration in merger talks with SpaceX
We see regulatory risk from both the US and Chinese governments.
stocks
Meta earnings: Early look at Muse adoption impresses investors
We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,923.00 | 17.20 | 0.19% |
| CAC 40 | 7,782.82 | 28.44 | -0.36% |
| DAX 40 | 25,181.65 | 190.10 | -0.75% |
| Dow JONES (US) | 52,215.16 | 652.82 | -1.23% |
| FTSE 100 | 10,690.36 | 34.67 | -0.32% |
| HKSE | 23,193.94 | 100.57 | 0.44% |
| NASDAQ | 25,955.34 | 53.52 | -0.21% |
| Nikkei 225 | 62,448.15 | 245.01 | -0.39% |
| NZX 50 Index | 13,733.93 | 12.91 | -0.09% |
| S&P 500 | 7,623.68 | 39.75 | -0.52% |
| S&P/ASX 200 | 8,808.40 | 13.20 | 0.15% |
| SSE Composite Index | 3,683.92 | 6.56 | -0.18% |